>
产品中心 >
Transfection >
Altogen/PEG-Liposome In Vivo Transfection Reagent/8.0 ml - 160 injections/5042
Description
ProductAvailABIlity:InStock(deliverywithin2-3businessdays,noextrachargefordrop-shipping).
Ordering:ToplaceanorderviacreditcardorPOuseAddtoCartbutton(creatinganaccountisnotrequired).
PEG-LiposomeInVivoTransfectionKit
siRNA,DNA andprotein invivodeliveryreagent
ModesofadmiNISTration:
- Systemicintravenous(i.v.)injection
- Directintratumoral(i.t.)injection
Altogen’sPEG-Liposome InVivoTransfectionReagent
- PEGylatedliposomebasedreagent
- NodetectabletoxicityorinflammatoryresponseduetobiodegradablePEGmodification
- Complexesarestableinserumforatleast16h
- Efficientdeliverytothespleen,kidney,pancreas,liver,andmultipletumortypesviasystemicadministration
- EfficientdeliveryofnegativelychargedmoleculesincludingsiRNA(shRNA,microRNA),plasmidDNA,andprotein
- Functionallytestedinmice
- ApplicableforplasmidDNA/siRNA(shRNA)co-injection
- DownloadPEG-Liposomeinvivotransfectionprotocol:[PDF][Word]
- DownloadPowerPointpresentationforPEG-Liposome invivotransfectionkit:[PPT]
- DevelopedandmanufacturedbyAltogenBiosystems
DATA
Figure1.Systemicadministration(i.v.)ofLiposome-PEGbasedInVivoreagentconjugatedwithsiRNAtargetingLaminA/CmRNAornon-silencingcontrolsiRNAfollowingtherecommendedprotocol.TissueswerecollectedandRNAisolated48hoursafterfirstinjection.SampleswereanalyzedbyqRT-PCRforLaminA/Cgeneexpressionlevels.RibosomalRNAlevelswereusedtonormalizetheLaminA/Cdata.Dataaremeans±SD(n=6).
Figure2.Intratumoraladministration(i.t.)ofLiposome-PEGbasedInVivoreagentconjugatedwithsiRNAtargetingLaminA/CmRNAornon-silencingcontrolsiRNAfollowingtherecommendedprotocol.TissueswerecollectedandRNAisolated48hoursafterfirstinjection.SampleswereanalyzedbyqRT-PCRforLaminA/Cgeneexpressionlevels.RibosomalRNAlevelswereusedtonormalizetheLaminA/Cdata.Dataaremeans±SD(n=6).
Figure3. Systemicadministration(i.v.)ofPEG-LiposomeInVivoTransfectionReagentconjugatedwith80ugofchemicallymodifiedsiRNAtargetingLaminA/CmRNAornon-silencingcontrolsiRNAfollowingtherecommendedprotocol.Tissues(Liver,Brain,Muscle,Kidney,Tumor,Heart,Spleen,Lung)werecollectedandtotalproteinfractionisolated72hoursafterfirstinjection.SampleswereanalyzedbyWesternBlotAnalysisforLaminA/Cgeneexpressionlevels.
Selected invivo transfectionproductcitations(ALTOGEN® INVIVO TransfectionKits usedinthefollowingpublications):
- Nature.2008454(7203):523-7.Innateimmunityinducedbycomposition-dependentRIG-I…Saitoetal[PDF]
- Am JPathology.2010177(4):1870-80.RoleofocularcomplementfactorHinamurinemodel…Lyzogubovetal[PDF]
- NatureBiotechnology.201129(4):341-5.DeliveryofsiRNAtothemousebrainby…Alvarez-Ervitietal [PDF]
- CancerResearch.201171(15):5144-53.InhibitionofmiR-193aexpressionby…Iliopoulosetal[PDF]
- RNA.201016(11):2108-19.RNaseLreleasesasmallRNAfromHCVRNAthatrefolds…Malathietal[PDF]
- Diabetologia.201255(7):2069-79.Thep47phox-andNADPHoxidaseorganiser1…Younetal [PDF]
- BritishJournalofCancer.2012 107(3):516-26.TIGARinducesp53-mediatedcell-cycle…Madanetal[PDF]
- Hypertension.201463(2):353-61.Tissuetransglutaminasecontributesto…Liuetal[PDF]
- Circulation Research.201015;107(8).Kruppel-likefactor-4transcriptionallyregulates…Cowanetal[PDF]
- Hypertension.201259(1):158-66.Roleofuncoupledendothelialnitricoxidesynthase…Gaoetal[PDF]
- JounalofBIOLOGicalChemistry.2012287(4):2907.Chaperoningofmutantp53protein…Gognaetal [PDF]
- PLoSPathogens.20128(8)Uridinecompositionofthepoly-U/UCtractofHCVRNA…Schnelletal[PDF]
- JProteomeRes.2012(11) Retinalproteomeanalysisinamousemodelofoxygen-induced…Kimetal[PDF]
- J TranslMed.201015;8:133.Preventionofhyperglycemia-inducedmyocardialapoptosis…Zhangetal[PDF]
- MolCellBiol.201333(7).SCO2inducesp53-mediatedapoptosisbyThr845phosphorylation…Madanetal[PDF]
- Hypertension.2015 65(2):430-9.Neurokinin3receptorandphosphocholinetransferase…Parchimetal [PDF]
- Gastroenterology.2011141(2) Differential typeIinterferon-mediatedautophagictrafficking…Desaietal[PDF]
- PLoSPathog.201410(10)ExosomesfromhepatitisCinfectedpatientstransmitHCV…Bukongetal[PDF]
PEG-LiposomeInVivoTransfectionReagent
AltogenResearchServices:
AltogenLabsprovidesGLP-compliantcontractresearchstudiesforpre-clinicalresearch,INDapplications,anddrugdevelopment.BiologyCROservices include:Xenograftmodels(30+),developmentofstablecelllines,ELISAassaydevelopment,cell-basedandtissuetargetedRNAistudies,safetypharm/toxassays,andotherstudies(visitAltogenLabs.com).
VolumeOptions:
- 0.5ml–10injections(Catalog#5040)
- 1.5ml–30injections(Catalog#5041)
- 8.0ml–160injections(Catalog#5042)
